Copyright
©The Author(s) 2023.
World J Nephrol. Dec 25, 2023; 12(5): 182-200
Published online Dec 25, 2023. doi: 10.5527/wjn.v12.i5.182
Published online Dec 25, 2023. doi: 10.5527/wjn.v12.i5.182
Figure 6 Meta-analysis of gliflozins’ effect on the all-cause mortality across left ventricular ejection fraction strata (versus placebo).
A: Left ventricular ejection fraction (LVEF) ≤ 30% vs > 30%; B: LVEF ≤ 40% vs > 40%; C: LVEF ≤ 45% vs LVEF > 45%; D: LVEF ≤ 50% vs LVEF > 50%; E: LVEF ≤ 60% vs LVEF > 60%. bper 100 person-years. LVEF: Left ventricular ejection fraction; N/A: Not available.
- Citation: Taheri S. Heterogeneity in cardiorenal protection by Sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: Systematic review and meta-analysis. World J Nephrol 2023; 12(5): 182-200
- URL: https://www.wjgnet.com/2220-6124/full/v12/i5/182.htm
- DOI: https://dx.doi.org/10.5527/wjn.v12.i5.182